Adverse effects of systemic isotretinoin therapy: A study of 78 patients

Journal of Pakistan Association of Dermatologists

Volumn 15, Issue 3, 2005, Pages 242-246

  Ahmed, Ijaz ^a,c   Wahid, Zarnaz ^b   Nasreen, Sarwat ^a  

^a ZIAUDDIN MEDICAL UNIVERSITY   (Pakistan)

^b DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

^c DHA ^*  (Pakistan)

Author keywords

Acne; Depression; Isotretinoin; Teratogenecity

Indexed keywords

ISOTRETINOIN;

ACNE; ADULT; ADVERSE DRUG REACTION; ARTICLE; BLOOD ANALYSIS; CENTRAL NERVOUS SYSTEM DISEASE; CHEILITIS; CONTROLLED STUDY; DEPRESSION; DESQUAMATION; DIZZINESS; DRUG SAFETY; EDEMA; EPISTAXIS; FACE ERYTHEMA; FEMALE; GASTROINTESTINAL SYMPTOM; GENITAL SYSTEM DISEASE; HEADACHE; HUMAN; INSOMNIA; KIDNEY FUNCTION TEST; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MUCOSAL DRYNESS; ONYCHOLYSIS; OUTPATIENT DEPARTMENT; PRURITUS; RESPIRATORY TRACT DISEASE; SKIN DISEASE; SORE THROAT; SYSTEMIC THERAPY; TERATOGENICITY; TINNITUS; VISUAL DISORDER; XEROSIS;

EID: 29244476897     PISSN: 15609014     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Wysowski DK, Swann J, Vega A. Use of isotretinoin (Accutane) in the United States: rapid increase from 1992 through 2000. J Am Acad Dermatol 2002; 46: 505-9.
2. Goulden V, Layton AM, WJ Cunliffe. Long-term safety of isotretinoin as a treatment for acne vulgaris. Br J Dermatol 1994; 131: 360-3.
3. Leautelabreze C, Gautie C, Labbe L, Taieb A. Infantile acne treated with oral isotretinoin. Annales de Dermatol et de Venereol 1998; 125: 132-4.
4. Alcalay J, Landau M, Zucker A. Analysis of laboratory data in acne patients treated with isotretinoin: is there really a need to perform routine laboratory tests? J Dermatol Treatment 2001; 12: 9-12.
5. Wysowski DK, Pitts M, Beitz J. Analysis of reports of depression and suicide in patients treated with isotretinoin. J Am Acad Dermatol 2001; 45: 515-9.
6. Al-Khawajah MM. Isotretinoin for acne vulgaris. Int J Dermatol 1996; 35: 212-5.
7. Bruno, N.P. Adverse Effects of Isotretinoin Therapy. Cutis 1984; 33: 484-489.
8. Cunliffe WJ, Van De Kerkhof PC, Caputo R et al. Roaccutane treatment guidelines: results of an international survey. Dermatology 1997; 194: 351-7.
9. Gandola M. Therapy of severe acne and acne rosacea with oral 13-cis-retinoic acid. Acta Vitaminol Enzymol 1984; 6: 325-37.
10. Almond-Roesler A, Blume-Peytavi U, Bisson S, Krahn M, Rohloff E, Orfanos CE. Monitoring of isotretinoin therapy by measuring the plasma levels of isotretinoin and 4-oxo-isotretinoin. Dermatology 1998; 196: 176-81.
11. Jacobs DG, Deutsch NL, Brewer M. Suicide, depression, and isotretinoin: is there a causal link? J Am Acad Dermatol 2001; 45: S168-75.
12. Wysowski DK, Beitz J. Methodological limitations of the study "Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide". Arch Dermatol 2001; 137: 1102-3.
13. Jick SS, Kremers HM, Vasilakis-Scaramozza C. Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide. Arch Dermatol 2000; 136: 1231-6.
14. Tangrea JA, Edwards BK, Taylor PR et al. Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: a multicenter clinical trial. J Natl Cancer Inst 1992; 84: 328-32.
15. Tangrea JA, Kilcoyne RF, Taylor PR et al. Skeletal hyperostosis in patients receiving chronic, very-low-dose isotretinoin. Arch Dermatol 1992; 128: 921-5.
16. Berbis P, Hun H, Geiger JM, Rognin C, Durand A, Serradimigni A. Acitretin (RO10-1670) and oral contraceptives: interaction study. Arch Dermatol Res 1998; 280: 388-9.